Viewing Study NCT00097227

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:19 AM
Ignite Modification Date: 2026-06-17 @ 5:48 PM
Study NCT ID: NCT00097227
Status: COMPLETED
Last Update Posted: 2010-04-09
First Post: 2004-11-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)
Sponsor: Eli Lilly and Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NSCLC View
None non-small View
None lung View
None IIIb View
None IV View
None Carboplatin View
None Paclitaxel View
None Cetuximab View
None Stage IIIB Non-Small Cell Lung Cancer View
None Stage IV Non-Small Cell Lung Cancer View